Free Trial

TriMas (NASDAQ:TRS) Stock Rating Upgraded by KeyCorp

TriMas logo with Industrials background

Key Points

  • TriMas has been upgraded from a "hold" rating to a "strong-buy" rating by KeyCorp, with estimates for future earnings growth.
  • The company's stock saw a 5.0% increase, opening at $37.47, with notable performance in recent earnings reporting $0.61 EPS for the last quarter, exceeding analysts' expectations.
  • Insider purchases significantly increased, with Director Adrianne Shapira acquiring 4,000 shares, indicating strong confidence in the company's future.
  • Need better tools to track TriMas? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

TriMas (NASDAQ:TRS - Get Free Report) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating in a note issued to investors on Tuesday, MarketBeat reports. The firm presently has a $45.00 price target on the industrial products company's stock. KeyCorp's target price would suggest a potential upside of 20.10% from the stock's previous close. KeyCorp also issued estimates for TriMas' Q3 2025 earnings at $0.57 EPS, FY2025 earnings at $2.09 EPS, Q2 2026 earnings at $0.73 EPS and Q3 2026 earnings at $0.67 EPS.

TRS has been the topic of several other reports. BWS Financial reissued a "buy" rating and set a $45.00 price target (up from $40.00) on shares of TriMas in a research report on Wednesday, July 30th. Wall Street Zen raised shares of TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st.

View Our Latest Report on TRS

TriMas Price Performance

Shares of NASDAQ TRS opened at $37.47 on Tuesday. The firm has a market cap of $1.52 billion, a PE ratio of 41.18 and a beta of 0.66. The company has a current ratio of 2.59, a quick ratio of 1.44 and a debt-to-equity ratio of 0.59. TriMas has a 1-year low of $19.33 and a 1-year high of $37.49. The company has a fifty day moving average price of $30.44 and a 200 day moving average price of $25.89.

TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.50 by $0.11. TriMas had a net margin of 3.83% and a return on equity of 11.49%. The firm had revenue of $274.76 million for the quarter, compared to analysts' expectations of $251.18 million. During the same period in the previous year, the firm posted $0.43 EPS. The company's revenue for the quarter was up 14.2% on a year-over-year basis. Research analysts predict that TriMas will post 1.69 earnings per share for the current fiscal year.

Insider Transactions at TriMas

In other news, Director Shawn Sedaghat bought 72,937 shares of the company's stock in a transaction dated Thursday, May 22nd. The shares were bought at an average cost of $26.16 per share, with a total value of $1,908,031.92. Following the acquisition, the director owned 1,883,758 shares in the company, valued at $49,279,109.28. This trade represents a 4.03% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Adrianne Shapira bought 4,000 shares of the company's stock in a transaction dated Thursday, June 5th. The stock was purchased at an average cost of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the acquisition, the director owned 8,476 shares in the company, valued at $218,850.32. This trade represents a 89.37% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 848,232 shares of company stock worth $21,644,995. 14.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Deutsche Bank AG grew its stake in TriMas by 45.6% in the 4th quarter. Deutsche Bank AG now owns 36,305 shares of the industrial products company's stock valued at $893,000 after buying an additional 11,363 shares during the last quarter. GAMMA Investing LLC grew its stake in TriMas by 3,802.9% in the 1st quarter. GAMMA Investing LLC now owns 14,948 shares of the industrial products company's stock valued at $350,000 after buying an additional 14,565 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in TriMas by 3.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company's stock valued at $568,000 after buying an additional 834 shares during the last quarter. Envestnet Asset Management Inc. grew its stake in TriMas by 44.5% in the 1st quarter. Envestnet Asset Management Inc. now owns 22,765 shares of the industrial products company's stock valued at $533,000 after buying an additional 7,016 shares during the last quarter. Finally, Wells Fargo & Company MN grew its stake in TriMas by 21.1% in the 4th quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company's stock valued at $928,000 after buying an additional 6,573 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company's stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Featured Articles

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines